You are here

  • Home
  • Archive
  • Volume 106, Issue 11
  • Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial

Article metrics

Article menu
Download PDFPDF
Clinical science
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 20211064941
Jun 2021623130
Jul 2021401817
Aug 2021272021
Sep 202130157
Oct 20214501814
Nov 20213421010
Dec 20214232413
Jan 2022322229
Feb 20224951713
Mar 20226981411
Apr 202245487
May 2022485812
Jun 20226062416
Jul 2022530195
Aug 2022706239
Sep 2022478286
Oct 20229865324
Nov 202210024934
Dec 20222191914
Jan 20234082340
Feb 20233743618
Mar 2023425199
Apr 20232872317
May 2023239249
Jun 2023188135
Jul 2023174136
Aug 202311185
Sep 202320885
Oct 2023250124
Nov 2023397208
Dec 20232331611
Jan 20241451811
Feb 20243952412
Mar 20246533616
Total12948762489